Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Physician-Editor Discusses Lessons Learned after 1 Year on the Job

  |  Issue: December 2018  |  

Dr. SeoPhilip Seo, MD, MHS, is an associate professor of medicine at the Johns Hopkins University School of Medicine, Baltimore. He is director of both the Johns Hopkins Vasculitis Center and the Johns Hopkins Rheumatology Fellowship Program.

ADVERTISEMENT
SCROLL TO CONTINUE

Erratum

In the November report, “2018 ACR Awards of Distinction,” a reporting error was made in the section about Jonathan Kay, MD, professor of medicine, the Timothy S. and Elaine L. Peterson Chair in Rheumatology, and director of clinical research for the Division of Rheumatology at the University of Massachusetts Medical School in Worcester. Dr. Kay has researched gadolinium-induced systemic fibrosis (formerly known as nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis), β2-microglobulin amyloidosis and other rheumatologic problems of patients with chronic kidney disease for the past three decades—not three years as stated. We regret the error.

References

  1. RheumPAC portal.
  2. Thrush G. Mulvaney, watchdog bureau’s leader, advises bankers on ways to curtail agency. The New York Times. 2018 Apr 24.

Related Articles

    November, a Busy Month for RheumPAC

    In November, RheumPAC will be leading its annual matching campaign and hosting two events at ACR Convergence 2022. Thanks to matching donors, every contribution in November will be amplified.

    I RheumPAC, Do You?

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.